Several head lice companies have recently released financial updates related to their head lice treatments.
Pernix therapeutics saw a stock price rise after the announcement of their 2014 Q4 earnings. The company products include the NATROBA head lice treatment.
Pediapharm announced Q3 financial year results, including strong and growing sales for their NYDA head lice treatment.
Tyratech have seen a sharp rise in shares, up over 40% in the last quarter, following recent distribution agreements for their Vamousse line of head lice treatments.